DXLG reevaluates FullBeauty merger as Q1 loss widens; comps improve but GLP-1 drugs reshape demand
Filed June 3, 2026 · Period ending May 2, 2026 · Compared to 10-Q May 29, 2025 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade DXLG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 8:39 PM